Cosmo Pharmaceuticals NV

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Cosmo Pharmaceuticals NV"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 182.02% vs -12.10% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1,320.19% vs -159.09% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "254.10",
          "val2": "90.10",
          "chgp": "182.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "150.00",
          "val2": "7.80",
          "chgp": "1,823.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "8.40",
          "chgp": "-98.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "1.30",
          "chgp": "38.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "126.90",
          "val2": "-10.40",
          "chgp": "1,320.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "544.30%",
          "val2": "-40.90%",
          "chgp": "58.52%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

254.10

90.10

182.02%

Operating Profit (PBDIT) excl Other Income

150.00

7.80

1,823.08%

Interest

0.10

8.40

-98.81%

Exceptional Items

1.80

1.30

38.46%

Consolidate Net Profit

126.90

-10.40

1,320.19%

Operating Profit Margin (Excl OI)

544.30%

-40.90%

58.52%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 182.02% vs -12.10% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1,320.19% vs -159.09% in Dec 2023

All Annual Results